APOBIOLOGIX Trademark

Trademark Overview

On Tuesday, May 19, 2015, a trademark application was filed for APOBIOLOGIX with the United States Patent and Trademark Office. The USPTO has given the APOBIOLOGIX trademark a serial number of 86634783. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Friday, March 8, 2024. This trademark is owned by Apotex Technologies Inc.. The APOBIOLOGIX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical preparations, prescription drugs, generic drugs, and biosimilar drugs for [hemopoetic] *hematopoietic* growth factors used for stimulating white blood cell production, and for the treatment of proliferative disorders, namely, angiogenic disorders including cancer ]

Drug product research development services
apobiologix

General Information

Serial Number86634783
Word MarkAPOBIOLOGIX
Filing DateTuesday, May 19, 2015
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateFriday, March 8, 2024
Registration Number5169202
Registration DateTuesday, March 28, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements

Description of MarkThe mark consists of a generally octagonal grouping of circles and semicircles to the left of a stylized rendering of the word "Apobiologix" with the letter "A" presented as a capital letter and the remaining letters presented in lower case lettering.
Certificate of Correction for RegistrationIn the statement, line 6, " hemopoetic" should be deleted, and hematopoietic should be inserted.
Goods and Services[ Pharmaceutical preparations, prescription drugs, generic drugs, and biosimilar drugs for [hemopoetic] *hematopoietic* growth factors used for stimulating white blood cell production, and for the treatment of proliferative disorders, namely, angiogenic disorders including cancer ]
Pseudo MarkAPO BIOLOGIC
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDrug product research development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 28, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPOTEX INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTORONTO M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto M9L1T9
CA
Party NameApotex Technologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M9L1T9
CA

Trademark Events

Event DateEvent Description
Monday, August 31, 2015ASSIGNED TO EXAMINER
Friday, May 22, 2015NEW APPLICATION ENTERED
Thursday, May 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 29, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, August 31, 2015NON-FINAL ACTION WRITTEN
Monday, August 31, 2015NON-FINAL ACTION E-MAILED
Monday, August 31, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 5, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 19, 2015ASSIGNED TO LIE
Thursday, November 19, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 2, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 22, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 16, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, August 16, 2016SOU EXTENSION 1 FILED
Tuesday, August 16, 2016SOU EXTENSION 1 GRANTED
Thursday, August 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, October 24, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 24, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 27, 201644(e) PETITION - RECEIVED
Thursday, October 27, 2016ASSIGNED TO PETITION STAFF
Friday, November 18, 2016PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, October 28, 2016PETITION INQUIRY LETTER ISSUED
Friday, November 4, 2016TEAS PETITION TO DIRECTOR RECEIVED
Tuesday, December 6, 2016NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 6, 2016CASE RETURNED TO EXAMINATION
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017REGISTERED-PRINCIPAL REGISTER
Friday, April 21, 2017TEAS SECTION 7 REQUEST RECEIVED
Monday, June 26, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 28, 2017CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, June 19, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 19, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 18, 2023TEAS SECTION 8 & 15 RECEIVED
Friday, March 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 8, 2024REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

apobiologix drugs disorders namely angiogenic including proliferative treatment drug development services